Brent Richards

CEO at 5 Prime Sciences

Speaker

Dr. Brent Richards is CEO of 5 Prime Sciences and a global leader in human genetics and translational medicine.

He is a Professor of Medicine and Human Genetics at McGill University, a Senior Lecturer at King's College London, and a practicing endocrinologist. With 18+ years of experience at the intersection of genomics, clinical research, and drug development, Brent has published over 400 peer-reviewed papers and led international efforts to identify disease-causing genes and move them toward the clinic.

His work has shaped clinical guidelines, launched successful biotech programs, and informed Board of Governors decisions for large pharma. He served on the International Scientific Advisory Board for Human Genetics at GSK and frequently advises investors and R&D leaders on how to integrate genetic evidence into decision-making.
At 5 Prime Sciences, Brent leads a team delivering multi-omic target validation, biomarker discovery, and patient enrichment strategies to top-tier pharma, biotech, and VC firms. His mission: use human genetics and causal biology to build better medicines.